risk stratification of plasma cell disorders
Published 5 years ago • 483 plays • Length 29:18Download video MP4
Download video MP3
Similar videos
-
28:51
diagnosis and risk stratification of plasma cell disorders (pt 1 of 5 - imf ash satellite)
-
0:24
risk stratification for mgus | dr. s. vincent rajkumar | oncology brothers
-
5:16
updated risk stratification model for smoldering multiple myeloma
-
17:48
mcrt phoenix 2017: mm diagnosis and risk stratification by shaji kumar, md
-
15:02
elevated plasma cells in ndmm pts linked to poor prognosis regardless of other factors
-
0:26
who is high-risk smoldering myeloma | dr. s. vincent rajkumar
-
5:54
circulating tumor plasma cells in the screened istopmm smoldering multiple myeloma cohort
-
51:06
myeloma 101 and frontline therapy - dr. craig cole: rcw san diego 2021
-
1:28
risk stratification models for smoldering myeloma
-
47:18
diagnosis and risk assessment in multiple myeloma
-
56:51
living well with myeloma: mgus, smoldering myeloma, and newly diagnosed
-
13:14
2020 treatment algorithm for multiple myeloma and conclusions (part 5 of 5 - imf ash 2019 satellite)
-
1:57
using molecular abnormalities for risk stratification in multiple myeloma at the time of diagnosis
-
4:51
risk stratification & treatment of multiple myeloma precursor conditions
-
2:29:01
new strategies for multiple myeloma care: next steps for the future
-
0:57
risk stratification in multiple myeloma
-
3:59
the importance of accurately defining high-risk myeloma and current risk stratification systems
-
2:41
identification of myeloma high-risk subclones with single-cell technologies
-
4:12
when should smoldering multiple myeloma patients start treatment?